SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?


To: AriKirA who wrote (3392)3/9/1999 1:33:00 PM
From: Justin Curran  Read Replies (1) | Respond to of 8117
 
Realistically what is going to move PYT higher other than large volume sales? They appear to be but a dream. The stock is heading for a year low with no support in sight. What to do? will PYT be at .80 by the summer? Or is it a buy? I believe that most people have gotten tired of waiting.



To: AriKirA who wrote (3392)3/9/1999 2:11:00 PM
From: LOR  Respond to of 8117
 
AriK, that "Market Efficiency" post was great

Quoting in part,
*****************************
""To these four kinds of information correspond three forms of market efficiencies.

The weak form of efficiency says that all public information about the old prices,
volumes and so on are included in the price of a security.

The middle form of efficiency says that all public information (thus, including non
published information that can be obtained by research) is included in the securities
price.

The strong form of efficiency includes all information (public or not)in the securities
price.

While the strong form of the Efficient Market Hypothesis is thought to be unrealistic,
the weak and the middle form are widely accepted for developed western capital
markets. ""
******************************

Based on the above, I believe PYNG is indeed priced according to the "middle form of
efficiency".

The research todate can be summarized as follows:

1) PYNG [ and others ] have workable "adult intraosseous infusion device" products,
2) the market for said devices is in the process of been developed but at this time can best be
described by the word "potential",
3) no credible independent organisation is officially indicating that there is a "product of
choice"
4) none of the four suppliers of adult intraosseous devices has announced the receipt of
major orders for their device for use on ""ADULTS"",
5) todate, the medical community "at large" has not established the roll of these devices in
"emergency" medicine,

***************************************
Only new information can affect the price. But new information appears randomly--so its
appearance can't be predicted
****************************************

Actually, ...it can be "predicted, forecasted and/or imagined in advance" and of course this has
been a major concern to PYNG investors who have seen that PYNG's forecasts have had
about the same accuracy as "long range" weather forecasts. Still, we all know that the sun will
someday shine on PYNG...or at least I believe it...The real question is whether or not it will be in
this or the next millinium.

**********************************************
In my opinion the current stock price has nothing to do with potential and everything with
lack of interest.
**********************************************
Actually, I suspect that there is considerable "interest" in PYNG but that investment managers
are asking "WHERE'S THE BEEF" which of course is a significant 'MASS PRODUCTION"
order.

GWB regarding your comment

"If however FAST1 was the only choice for the military, investors would naturally feel a little
more secure,and this would reflect in the share price."

I believe the GOOD NEWS is:

1) that the market is more then big enough for more then one manufacturer of intraosseous
products AND
2) that the military have accepted the FAST-1 and probably do prefer it "informally" for
the vast majority of military environments,
3) that PYNG has done as good or better in establishing itself for "mass production" sales
of "ADULT" devices then it's competitors and that PYNG's performance in this area far
exceeds its performance in "shareholder information" releases,

Grant MacMillan's comment

"" So, until Pyng releases news about orders, including how much, my guess is that
we're stuck here. Certainly not what I expected a year ago. ""

is I.M.H.O 100% on the mark. It is time for the "kettle" to get off the "pot" and land that first
M.P. order. I have no doubts that once that order has been logged that shareholders will be
immediately advised as it would seem almost criminal not to do so in light of PYNG's history.
...... And of course that announcement may be only seconds, minutes, hours, days or months
away !!!

I also believe that once the "BEEF" has been announced that there will be a minor stampead
on the part of investment managers to get in before the price goes through the roof as the
announcement that a major order has been placed will tell the investment community that
"adult intraosseous infusion devices" have finally been accepted as viable "products" as
opposed to mere research toys.

Good luck to all,

LOR